Cerus Endovascular
Cerus Endovascular is a privately held Oxford-based medical device company founded in 2011 that designs and develops interventional neuroradiology devices and delivery systems for the treatment of cerebrovascular conditions.
- Company typePrivate
- Founded2011
- HeadquartersOxford, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cerus Endovascular does
Cerus Endovascular is a privately held, for-profit medical device company founded in 2011 and headquartered in Oxford, United Kingdom. The company designs and develops interventional neuroradiology devices and delivery systems, targeting the neurovascular intervention market where clinicians treat intracranial aneurysms, stroke, and other cerebrovascular conditions using catheter-based approaches.
The company's product offering centers on the engineering of specialty implants and the catheter-based delivery systems used to deploy them inside the cerebral vasculature. Operating with a micro-cap headcount of 1-10 employees, the company is positioned at the early-stage development phase typical of pre-commercial neurovascular startups, with R&D, design, and prototyping as its core functions. No specific product SKUs, FDA/CE mark filings, clinical trial data, or named reference customers are disclosed in the available material.
Cerus Endovascular's business model is consistent with early-stage medical device commercialization: it has historically funded operations through equity capital — a 2013 seed round of approximately $2.33 million from Mid Atlantic Bio Angels and The North West Fund, followed by an undisclosed second round in February 2020 — and is presumed to be pursuing a pathway of regulatory clearance (FDA/CE mark) and either direct sales or licensing/distribution partnerships with larger neurovascular players (e.g., Stryker, Medtronic, MicroVention, Penumbra) once approvals are obtained. The company has no disclosed revenue, publicly disclosed pricing, or named end customers in the current dataset.
Cerus Endovascular firmographics
Firmographics- Name
- Cerus Endovascular
- Website
- https://cerusendo.com
- Company type
- Private
- Founded year
- 2011
- Headcount range
- 1–10 employees
- Short description
- Cerus Endovascular is a privately held Oxford-based medical device company founded in 2011 that designs and develops interventional neuroradiology devices and delivery systems for the treatment of cerebrovascular conditions.
- Ownership category
- akta.pro rank
Cerus Endovascular industry classification
Industry- Product category
- Neurovascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
- akta.pro secondary industry
- Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)
Keywords
Where Cerus Endovascular is headquartered
LocationHeadquarters
- HQ city
- Oxford
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Cerus Endovascular business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations
Cerus Endovascular product offering
Product offeringCore offering
Cerus Endovascular designs and develops interventional neuroradiology devices and delivery systems used in the treatment of cerebral aneurysms and other neurovascular conditions. The company's core focus is on the engineering of specialised implants and the delivery platforms that deploy them within intracranial vasculature.
Differentiator
Problem solved
Functional benefit
Companies that use Cerus Endovascular
Customer profileIdeal customer profiles1 record
Cerus Endovascular technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Cerus Endovascular partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Cerus Endovascular competitors and assessment
Company assessmentDirect peers
- Penumbra: Penumbra is a leading neurovascular and peripheral vascular device company whose stroke/thrombectomy portfolio directly competes with Cerus Endovascular's interventional neuroradiology focus. Both target mechanical thrombectomy and related neurovascular procedures.
- Terumo Neuro (MicroVention): Terumo Neuro (formerly MicroVention) develops coils, flow diverters, and access devices for interventional neuroradiology — a directly comparable neurovascular device peer targeting the same specialists and procedures as Cerus Endovascular.
- Balt Group: Balt Group manufactures and distributes interventional neuroradiology products including coils, stents, and access devices, directly overlapping with Cerus Endovascular's device portfolio.
Broad incumbents
- Stryker Neurovascular: Stryker's Neurovascular business (with products like Surpass Elite flow diverter) is a major incumbent in the neurovascular space. Cerus competes with Stryker's neurovascular offerings and aligns with their stated focus on stroke and aneurysm intervention.
- Medtronic Neurovascular: Medtronic's Neurovascular franchise spans coils, flow diversion, and access devices used in interventional neuroradiology. It is a broad incumbent competing in the same procedure categories as Cerus Endovascular.
- Cerenovus (Johnson & Johnson MedTech): Cerenovus, J&J's neurovascular business, offers coils, flow diverters, and stroke intervention devices. As a broad incumbent, it competes in the same interventional neuroradiology procedural space as Cerus Endovascular.
Emerging players
- Rapid Medical: Rapid Medical is an emerging neurovascular company developing adjustable stent retrievers and flow diverters, competing directly with Cerus in the interventional neuroradiology device category.
- phenox GmbH: phenox develops flow diverters and implant-assisted devices for intracranial aneurysms and stroke, making it a directly comparable emerging neurovascular device competitor.
- Acandis GmbH: Acandis is a specialist European neurovascular device company developing intracranial implants, flow diverters, and delivery systems — closely comparable to Cerus's interventional neuroradiology devices.
- InspireMD: InspireMD develops neurovascular and carotid scaffold/stent devices for stroke prevention and treatment — an adjacent emerging neurovascular device competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Cerus Endovascular social profiles
Digital presenceCerus Endovascular financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cerus Endovascular leadership team
Management profileNumber of profiles
Profiles1 record
Cerus Endovascular funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cerus Endovascular M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cerus Endovascular
What does Cerus Endovascular do?
Cerus Endovascular designs and develops interventional neuroradiology devices and delivery systems used in the treatment of cerebral aneurysms and other neurovascular conditions. The company's core focus is on the engineering of specialised implants and the delivery platforms that deploy them within intracranial vasculature.
When was Cerus Endovascular founded?
Cerus Endovascular was founded in 2011. It employs 1 to 10 people.
Where is Cerus Endovascular based?
Cerus Endovascular is headquartered in Oxford, United Kingdom, in the Europe region.
Who are Cerus Endovascular's main competitors?
Direct peers on record are Penumbra, Terumo Neuro (MicroVention) and Balt Group. Broad incumbents are Stryker Neurovascular, Medtronic Neurovascular and Cerenovus (Johnson & Johnson MedTech). Emerging players are Rapid Medical, phenox GmbH, Acandis GmbH and InspireMD.
Does Cerus Endovascular have an API?
No public API is recorded for Cerus Endovascular.
What industry is Cerus Endovascular in?
Cerus Endovascular's product category is Neurovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAEAD, Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts). Its NAICS code is 339112 and its SIC code is 3841.